Oxus America

Oxus America provides specialized engineering services and manufacturing solutions for both medical and non-medical sectors, focusing on Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) products. Founded by Gary Abusamra, Oxus America is headquartered in Rochester Hills, US. The company specializes in contract engineering and manufacturing services, predominantly for complex electro-mechanical medical devices. In April 2012, Oxus America raised Seed financing from Michigan Pre-Seed Capital Fund (Ann Arbor SPARK) for undisclosed financial terms.

The firm has executed 1 deal to date. Oxus America specializes in engineering services and manufacturing solutions for both medical and non-medical sectors, focusing primarily on Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) products. Their core offerings include contract engineering and manufacturing services, particularly for complex electro-mechanical medical devices. Additionally, Oxus designs and produces high-quality aftermarket service parts specifically for respiratory equipment, addressing the needs of healthcare providers and patients reliant on such technologies.

Their expertise in gas separation technology further enhances their product suite, which serves a diverse clientele, including hospitals, medical device companies, and other entities requiring specialized manufacturing services. Oxus markets its products and services primarily in North America, with outreach extending into select international markets, catering to a global demographic of healthcare professionals and equipment manufacturers. Oxus America's revenue is generated through a structured transaction model involving B2B partnerships, primarily with medical device companies and healthcare providers. The firm engages in direct sales and contract manufacturing agreements, where clients may commission bespoke engineering services or procure aftermarket service parts.

The company’s flagship offerings, such as engineered parts for respiratory devices and contract manufacturing solutions, facilitate ongoing collaborations with its clients. Pricing strategies may involve project-based fees for engineering services or sales agreements for manufactured components, helping to establish long-term relationships with key clients in the medical device industry. The consistent demand for regulatory-compliant medical components bolsters the financial foundation of Oxus, positioning it well within an evolving market landscape. Oxus America aims to advance its product offerings in the medical sector with the introduction of new engineered components designed specifically for advanced respiratory devices, with anticipated launches in late 2023.

The company also plans to expand its distribution network into European and Asian markets by 2024, targeting key healthcare hubs to enhance market penetration. The recent Seed financing raised in April 2012 will support the development of these new products and the expansion efforts, facilitating broader access to their specialized manufacturing services within these new regions.